SEC Company Response from BioScience Health Innovations, (BHIC) — Jan 2, 2020

BioScience Health Innovations, Inc.
Date: Jan. 2, 2020 · CIK: 0001784440 · Accession: 0001165527-20-000001

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 333-234487

Date

January 2, 2020

Author

President & C.E.O.

Form

CORRESP

Company

BioScience Health Innovations, Inc.

Letter

NOWTRANSIT INC

Manchester

20, Ayres Road

England, M16 9NB

January 2, 2020

VIA EDGAR

United States Securities and Exchange Commission

100 F Street, N.E.

Washington, DC 20549

Attention:

Division of Corporation Finance

Office of Telchnology

Re: Nowtransit Inc Registration Statement on Form S-1

File No. 333-234487

REQUEST FOR ACCELERATION OF EFFECTIVENESS

Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Nowtransit Inc (the " Registrant ") hereby requests acceleration of the effective date of its Registration Statement on Form S-1 (File No. 333-234487), as amended (the “Registration Statement”), so that it may become effective at 1:00 p.m. Eastern Daylight Time on January 05, 2020, or as soon as practicable thereafter.

•

Should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing.

•

The action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the company from its full responsibility for the adequacy and accuracy of the disclosure in the filing.

•

The company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

Yours truly,

Nowtransit Inc

Per: /s/ Ivan Homici

Ivan Homici, CEO

President & C.E.O.

cc: Laxague Law, Inc.

Show Raw Text

CORRESP
1
filename1.htm

    NOWTRANSIT INC

      Manchester

      20, Ayres Road

      England, M16 9NB

    January 2, 2020

    VIA EDGAR

    United States Securities and Exchange Commission

    100 F Street, N.E.

    Washington, DC  20549

    Attention:

    Division of Corporation Finance

    Office of Telchnology

    Re:            Nowtransit Inc
    Registration Statement on Form S-1

    File No. 333-234487

    REQUEST FOR ACCELERATION OF EFFECTIVENESS

    Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Nowtransit Inc (the " Registrant ") hereby requests
      acceleration of the effective date of its Registration Statement on Form S-1 (File No. 333-234487), as amended (the “Registration Statement”), so that it may become
      effective at 1:00 p.m. Eastern Daylight Time on January 05, 2020, or as soon as practicable thereafter.

              •

              Should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose
                the Commission from taking any action with respect to the filing.

              •

              The action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not
                relieve the company from its full responsibility for the adequacy and accuracy of the disclosure in the filing.

              •

              The company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the
                Commission or any person under the federal securities laws of the United States.

    Yours truly,

    Nowtransit Inc

    Per: /s/ Ivan
            Homici

    Ivan Homici, CEO

    President & C.E.O.

    cc:  Laxague Law, Inc.

SecProbe.io